Axiom MRC has updated all it's market research reports with the Economic Impact Analysis of COVID19 Pandemic on the market. Our team of analyst are following Comprehensive Three Dimensional (3D) Research Methodology along with large number primary interviews with key industry participants to bring insightful market reports to meet the current market requirements.
Neonatal ventilators are artificial respiration devices that have been specially developed for use with newborns. Preterm newborns are more susceptible to various complications such as hypothermia due to heat loss, reduced fat and glycogen. Neonatal ventilators are designed to provide infants and newborns with artificial gas support in the form of gas supply and gas evacuation, especially oxygen and carbon dioxide. Monitoring neonates is one of the most difficult tasks. Introducing various advanced neonatal infant care equipment has remained key to manage complications associated with neonatal health. Advancements and growing awareness about pregnancy complications and maternal-neonatal health have increased the need for better neonatal care.
The factors driving the market growth in United States are increasing incidence of preterm births with respiratory disorders and mortality rates are expected to increase demand for neonatal ventilators, which in turn is expected to fuel the neonatal ventilator market growth in the forecast period. Moreover, timely technological advancements in neonatal ventilators with increasing applications in neonates with respiratory problems will boost industry growth. Furthermore, growing birth rate in developing countries is expected to propel the growth of neonatal ventilators market.
The exclusive COVID 19 impact analysis report by Axiom MRC provides a 360 degree analysis of micro and macro-economic factors on the United States neonatal ventilators market. In addition, complete analysis of changes on the United States neonatal ventilators market expenditure, economic and international policies on supply and demand side. The report also studies the impact of pandemic on United States economies, international trade, business investments, GDP and marketing strategies of key players present in the market. There was a positive effect and growth in the demand for neonatal ventilators in COVID-19 pandemic. Growing incidences of pandemic infections such as COVID-19 boosted the United States neonatal ventilators market growth in the forecasted period.
Neonatal ventilators market comprises of different market segments like by product, mode, mobility, end users.
By product, the neonatal ventilators market includes key segment of invasive ventilators, non-invasive ventilators. The invasive neonatal ventilator market is expected lead and witnesses a significant growth in the forecast period. This is majorly due to their wide usage in intensive care unit of newborn babies and increasing preterm births with respiratory disorders and mortality rates. The invasive ventilators are used in ICU of new born neonates with respiratory illness or respiratory failures due to preterm birth. Increasing adoption of invasive neonatal ventilators advance technology is expected to propel the growth of neonatal ventilators market growth in the United States.
The neonatal ventilators market is available in the market by different mode pressure mode ventilation, combined mode ventilation, volume mode ventilation. The pressure mode ventilation is most preferred across the hospitals due to increase in number of preterm births having respiration difficulties. Manufacturers are highly investing to meet the rising demand for pressure mode ventilation for neonatal infant care equipments especially thermoregulation devices. Advancements and growing awareness about pregnancy complications and maternal-neonatal health have raised the need for better neonatal care.
The neonatal ventilators by mobility are segmented into intensive care ventilators, portable/transportable ventilators. The intensive care ventilators are expected to dominate the market in the forecast period. Due to the ongoing COVID-19 pandemic that has significantly influenced the deployment of intensive care ventilators neonatal ventilators in the United States. As the intensive care ventilators are extensively used in ICU To assist people in breathing when it gets uneasy for the patients to breath. Also the portable neonatal ventilator segment is expected grow in the forecast period. Portable ventilators provide long term support who do not require complex critical ventilators.
The neonatal ventilators market finds its major end user in hospitals, nursing homes, clinics, ambulatory surgical centers. The hospital segment dominates the market owning to the wide usage of neonatal ventilators in hospital setting. Neonatal ventilators are widely used for the treatment of new born babies with breathing disorders, respiratory failure or due to the development of lung infections because of pre term birth. The neonatal ventilators provide decision support, advance monitoring, optimal synchrony and flexible mask options to improve neonates comfort and to accelerate their path to natural breathing.
The key players in neonatal ventilators market are Air Liquide, VYAIRE, Hamilton Medical, Breas Medical, Drägerwerk AG & Co. KGaA, GENERAL ELECTRIC COMPANY, Koninklijke Philips N.V., Getinge AB, ResMed, Smiths Medical, Inc., Fisher & Paykel Healthcare Limited, Asahi Kasei Medical Co., Ltd., Sechrist, Allied Healthcare Products, Inc., NIHON KOHDEN CORPORATION, Airon Corporation, SCHILLER, Philips Healthcare, Medtronic plc
April 2020, Philips Healthcare launched mechanical ventilators named Philips Respironics E30 Ventilator as a readily available ventilation alternative during the COVID-19 crisis in situations where full-featured, critical care ventilators are not available. Philips will begin production immediately, ramping up outputs on an ongoing basis with expectations of producing 15,000 units per week
April 2020, Philips partnered with Flex and Jabil to expand its hospital ventilator assembly lines and strengthen its supply chain. This partnership will enable the company to produce 4,000 hospital ventilators per week by the third quarter of 2020. Fully featured hospital ventilators to invasively treat COVID-19 patients with respiratory insufficiency in critical care environments - such as the Philips Trilogy EV300 and Philips Respironics V60 - are complex medical devices.
March 2019, ResMed acquired HB Healthcare to increase the company’s customer base and strengthen its wider network of trusted distributor partners. ResMed a global leader in cloud-connected sleep and respiratory care devices in more than 120 countries.
The report analyses the neonatal ventilators market based on different market segments like by product, mode, mobility and end users. By product, the neonatal ventilators market includes key segment of invasive ventilators, non-invasive ventilators. The invasive neonatal ventilator market is expected lead and witnesses a significant growth in the forecast period. This is majorly due to their wide usage in intensive care unit of newborn babies and increasing preterm births with respiratory disorders and mortality rates. The neonatal ventilators market is available in the market by different mode pressure mode ventilation, combined mode ventilation, volume mode ventilation. The pressure mode ventilation is most preferred across the hospitals due to increase in number of preterm births having respiration difficulties. The neonatal ventilators by mobility are segmented into intensive care ventilators, portable/transportable ventilators. The intensive care ventilators are expected to dominate the market in the forecast period. Due to the ongoing COVID-19 pandemic that has significantly influenced the growth of segment in the region. The neonatal ventilators market finds its major end user in hospitals, nursing homes, clinics, ambulatory surgical centers. The hospital segment dominates the market owning to the wide usage of neonatal ventilators in hospital setting.
Why to buy this report :
